Chemoinformaics analysis of 2-Ethyl-3-methylpyrazine
| Molecular Weight | 122.171 | nRot | 1 |
| Heavy Atom Molecular Weight | 112.091 | nRig | 0 |
| Exact Molecular Weight | 122.084 | nRing | 1 |
| Solubility: LogS | -7.482 | nHRing | 1 |
| Solubility: LogP | 11.953 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 20.5579 |
| nHD | 0 | BPOL | 12.3121 |
| QED | 0.137 |
| Synth | 2.14 |
| Natural Product Likeliness | 0.424 |
| NR-PPAR-gamma | 0.262 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.023 |
| HIA | 0.005 |
| CACO-2 | -5.197 |
| MDCK | 0.00000463 |
| BBB | 0.004 |
| PPB | 0.994077 |
| VDSS | 3.233 |
| FU | 0.00940719 |
| CYP1A2-inh | 0.047 |
| CYP1A2-sub | 0.139 |
| CYP2c19-inh | 0.102 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.967 |
| CYP2d6-inh | 0.112 |
| CYP2d6-sub | 0.021 |
| CYP3a4-inh | 0.144 |
| CYP3a4-sub | 0.013 |
| CL | 5.049 |
| T12 | 0.018 |
| hERG | 0.458 |
| Ames | 0.005 |
| ROA | 0.003 |
| SkinSen | 0.978 |
| Carcinogencity | 0.014 |
| EI | 0.922 |
| Respiratory | 0.244 |
| NR-Aromatase | 0.116 |
| Antiviral | No |
| Prediction | 0.904072 |